2-Clorodeoxyadenosine in therapy of children with Langerhans cell histiocytosis

2-Clorodeoxyadenosine in therapy of children with Langerhans cell histiocytosis

Standard therapy of high risk patients with Langerhans cell histiocytosis (LCH) is associated with essential risk of therapy failure. In the present study results of 2-clorodeoxyadenosine usage as alternative therapy in this group of patients are analyzed. In this study 31 patients with multisystem...

Full description

Saved in:
Bibliographic Details
Main Authors: G. G. Solopova, D. D. Baidildina, L. I. Zharikova, I. I. Kalinina, U. N. Petrova, Ye. V. Suntsova, O. V. Goronkova, L. A. Hachatryan, V. V. Sinitsina, G. A. Novichkova, A. A. Maschan, M. A. Maschan
Format: Article
Language:Russian
Published: ABV-press 2022-11-01
Series:Онкогематология
Subjects:
langerhans cell histiocytosis
2-clorodeoxyzdenosine
cytosine-arabinoside
polychemotherapy
Online Access:https://oncohematology.abvpress.ru/ongm/article/view/725
Tags: Add Tag
No Tags, Be the first to tag this record!
Login for hold and recall information

Internet

https://oncohematology.abvpress.ru/ongm/article/view/725

Similar Items